Product Information
EXELON 13.3 MG/24HR PATCH is a brand product labeled by Novartis Pharmaceuticals Corporation, priced at $22.0078 per EA under NDC 00078050315. Its NADAC has been published 540 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the rivastigmine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
13.3 mg/24h
Manufacturer
Novartis Pharmaceuticals CorporationNDC
00078050315
Classification
Brand
Dosage Form
PATCH, EXTENDED RELEASE
Route
TRANSDERMAL
Last Updated
9/17/2025
Active Ingredients
RIVASTIGMINEApproval Type
New Drug (NDA)
FDA Application
NDA022083On Market Since
7/6/2007
Pharmacological Classes
Price Statistics
The NADAC for EXELON 13.3 MG/24HR PATCH has been published 540 times since Nov 28, 2013, and over the history we have for it it has risen 119.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.0078 per EA |
|---|---|
| All-time high | $22.0078 (Jun 24, 2026) |
| All-time low | $10.0487 (Nov 28, 2013) |
| 52-week high | $22.0078 |
| 52-week low | $21.9729 |
| Median price | $21.8391 |
| Average price | $19.0500 |
| Largest weekly change | +19.9% (Apr 15, 2015) |
| Weeks tracked | 540 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 92% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EXELON 13.3 MG/24HR PATCH?
The current National Average Drug Acquisition Cost (NADAC) for EXELON 13.3 MG/24HR PATCH, manufactured by Novartis Pharmaceuticals Corporation, is $22.0078 per EA (NDC 00078050315), effective Jun 24, 2026.
How has the price of EXELON 13.3 MG/24HR PATCH changed over time?
Over the history we have for it, the NADAC for EXELON 13.3 MG/24HR PATCH has risen 119.0%. It has been tracked across 540 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EXELON 13.3 MG/24HR PATCH?
Since Nov 28, 2013, the NADAC for EXELON 13.3 MG/24HR PATCH has ranged from a low of $10.0487 (Nov 28, 2013) to a high of $22.0078 (Jun 24, 2026), with a median of $21.8391 per EA.
Are there cheaper alternatives to EXELON 13.3 MG/24HR PATCH?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 13.3 MG/24HR PTCH, is $1.8531 per EA — about 92% below EXELON 13.3 MG/24HR PATCH.
Who manufactures EXELON 13.3 MG/24HR PATCH?
EXELON 13.3 MG/24HR PATCH (NDC 00078050315) is labeled by Novartis Pharmaceuticals Corporation, and CMS classifies it as a brand product.
Related Drugs
Same classification